// App-Quantinova.ai

: Single inhaler triple therapy in patients with COPD: patient-reported dyspnoea and health status from the IMPACT Trial

Researchers

Presenter

  • Maggie Tabberer

Principal Investigators

  • Christine Elaine Jones

  • Sally Kilbride

  • Gerard J Criner

  • Peter Lange

  • Meilan K Han

  • Fernando Martinez

  • David A Lipson

Medical Centers

  • GSK, Middlesex, United Kingdom,

  • NIH/NIEHS, Research Triangle Park, United States of America

  • Lewis Katz School of Medicine at Temple University, Philadelpha , United States of America

  • University of Copenhagen, Copenhagen E, Denmark

  • NewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, United States of America

  • CSL Behring, King of Prussia, United States of America

Locations

  • United Kingdom

  • United States

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • Catalase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved